These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 14610219)

  • 21. Pharmacokinetics of intravenously administered stealth liposomal doxorubicin modulated with verapamil in rats.
    Wang JC; Liu XY; Lu WL; Chang A; Zhang Q; Goh BC; Lee HS
    Eur J Pharm Biopharm; 2006 Jan; 62(1):44-51. PubMed ID: 16126379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myelotoxicity and RBE of 211At-conjugated monoclonal antibodies compared with 99mTc-conjugated monoclonal antibodies and 60Co irradiation in nude mice.
    Elgqvist J; Bernhardt P; Hultborn R; Jensen H; Karlsson B; Lindegren S; Warnhammar E; Jacobsson L
    J Nucl Med; 2005 Mar; 46(3):464-71. PubMed ID: 15750160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isostructural folate conjugates radiolabeled with the matched pair 99mTc/188Re: a potential strategy for diagnosis and therapy of folate receptor-positive tumors.
    Müller C; Schubiger PA; Schibli R
    Nucl Med Biol; 2007 Aug; 34(6):595-601. PubMed ID: 17707798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of the glucantime on the kinetic of biodistribution of radiopharmaceuticals in Wistar rats.
    Xavier Holanda CM; Cavalcanti Jales RL; Almeida Catanho MT; Holanda Leite RC; Lopes de Brito LM; Jales-Junior LH; Brandao KC; Amorim LF; de Brito Tiago GG; Gomes ML; Bernardo-Filho M
    Cell Mol Biol (Noisy-le-grand); 2002 Nov; 48(7):761-5. PubMed ID: 12619972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of a 99mTc labeled anti-TNFalpha monoclonal antibody in Crohn's disease: in vitro and in vivo studies.
    D'Alessandria C; Malviya G; Viscido A; Aratari A; Maccioni F; Amato A; Scopinaro F; Caprilli R; Signore A
    Q J Nucl Med Mol Imaging; 2007 Dec; 51(4):334-42. PubMed ID: 17464276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dose dependency of pharmacokinetics and therapeutic efficacy of pegylated liposomal doxorubicin (DOXIL) in murine models.
    Gabizon A; Tzemach D; Mak L; Bronstein M; Horowitz AT
    J Drug Target; 2002 Nov; 10(7):539-48. PubMed ID: 12683721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Asymmetrical nitrido tc-99m heterocomplexes as potential imaging agents for benzodiazepine receptors.
    Boschi A; Uccelli L; Duatti A; Bolzati C; Refosco F; Tisato F; Romagnoli R; Baraldi PG; Varani K; Borea PA
    Bioconjug Chem; 2003; 14(6):1279-88. PubMed ID: 14624645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is (99m)Tc-labelled pamidronate a better agent than (99m)Tc-medronate for bone imaging?
    Kumar V; Kumar D; Howman-Giles RB; Little DG
    Nucl Med Commun; 2007 Feb; 28(2):101-7. PubMed ID: 17198350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of doxorubicin levels in whole tumor and tumor nuclei in murine breast cancer tumors.
    Laginha KM; Verwoert S; Charrois GJ; Allen TM
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6944-9. PubMed ID: 16203786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intraoperative therapy with liposomal drug delivery: retention and distribution in human head and neck squamous cell carcinoma xenograft model.
    Wang SX; Bao A; Phillips WT; Goins B; Herrera SJ; Santoyo C; Miller FR; Otto RA
    Int J Pharm; 2009 May; 373(1-2):156-64. PubMed ID: 19429301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pyrazolyl derivatives as bifunctional chelators for labeling tumor-seeking peptides with the fac-[M(CO)3]+ moiety (M = 99mTc, Re): synthesis, characterization, and biological behavior.
    Alves S; Paulo A; Correia JD; Gano L; Smith CJ; Hoffman TJ; Santos I
    Bioconjug Chem; 2005; 16(2):438-49. PubMed ID: 15769099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biodistribution, pharmacokinetics and imaging of (188)Re-BMEDA-labeled pegylated liposomes after intraperitoneal injection in a C26 colon carcinoma ascites mouse model.
    Chen LC; Chang CH; Yu CY; Chang YJ; Hsu WC; Ho CL; Yeh CH; Luo TY; Lee TW; Ting G
    Nucl Med Biol; 2007 May; 34(4):415-23. PubMed ID: 17499731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiolabeling and Quantitative In Vivo SPECT/CT Imaging Study of Liposomes Using the Novel Iminothiolane-
    Varga Z; Szigyártó IC; Gyurkó I; Dóczi R; Horváth I; Máthé D; Szigeti K
    Contrast Media Mol Imaging; 2017; 2017():4693417. PubMed ID: 29097923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of dose and animal species on accelerated blood clearance of PEGylated liposomal doxorubicin.
    Suzuki T; Ichihara M; Hyodo K; Yamamoto E; Ishida T; Kiwada H; Kikuchi H; Ishihara H
    Int J Pharm; 2014 Dec; 476(1-2):205-12. PubMed ID: 25280884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Uptake kinetics of 99mTc-MAG3-antisense oligonucleotide to PCNA and effect on gene expression in vascular smooth muscle cells.
    Zhang YR; Zhang YX; Cao W; Lan XL
    J Nucl Med; 2005 Jun; 46(6):1052-8. PubMed ID: 15937319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetic and cytotoxic studies of pegylated liposomal daunorubicin.
    Song H; Zhang J; Han Z; Zhang X; Li Z; Zhang L; Fu M; Lin C; Ma J
    Cancer Chemother Pharmacol; 2006 May; 57(5):591-8. PubMed ID: 16133530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Necrosis avidity of (99m)Tc(CO)3-labeled pamoic acid derivatives: synthesis and preliminary biological evaluation in animal models of necrosis.
    Fonge H; Chitneni SK; Lixin J; Vunckx K; Prinsen K; Nuyts J; Mortelmans L; Bormans G; Ni Y; Verbruggen A
    Bioconjug Chem; 2007; 18(6):1924-34. PubMed ID: 17929883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravenous technetium-99m labelled PEG-liposomes in horses: a safety and biodistribution study.
    Underwood C; van Eps AW; Ross MW; Laverman P; van Bloois L; Storm G; Schaer TP
    Equine Vet J; 2012 Mar; 44(2):196-202. PubMed ID: 21696436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of liposomal doxorubicin (TLC-D99; Myocet) in patients with solid tumors: an open-label, single-dose study.
    Mross K; Niemann B; Massing U; Drevs J; Unger C; Bhamra R; Swenson CE
    Cancer Chemother Pharmacol; 2004 Dec; 54(6):514-24. PubMed ID: 15322827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravenous administration of 99mTc-HMPAO-labeled human mesenchymal stem cells after stroke: in vivo imaging and biodistribution.
    Detante O; Moisan A; Dimastromatteo J; Richard MJ; Riou L; Grillon E; Barbier E; Desruet MD; De Fraipont F; Segebarth C; Jaillard A; Hommel M; Ghezzi C; Remy C
    Cell Transplant; 2009; 18(12):1369-79. PubMed ID: 19849895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.